Clinical Utility of Methylation-Specific Multiplex Ligation-Dependent Probe Amplification for the Diagnosis of Prader–Willi Syndrome and Angelman Syndrome
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Prader–Willi syndrome (PWS) and Angelman syndrome (AS) are genomic imprinting disorders that are mainly caused by a deletion on 15q11-q13, the uniparental disomy of chromosome 15, or an imprinting defect. We evaluated the utility of methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) as a diagnostic tool and for demonstrating the relationship between molecular mechanisms and clinical presentation. Methods: We performed MS-MLPA using DNA samples from 93 subjects (45 PWS, 24 AS, and 24 non-PWS/AS controls) who had previously undergone MS-PCR for the diagnosis of PWS/AS. We compared the results of both assays, and patients’ clinical phenotypes were reviewed retrospectively. Results: MS-MLPA showed a 100% concordance rate with MS-PCR. Among the 45 PWS patients, 26 (57.8%) had a deletion of 15q11-q13, and the others (42.2%) had uniparental disomy 15 or an imprinting defect. Among the 24 AS patients, 16 (66.7%) had a deletion of 15q11-q13, 7 AS patients (29.2%) had uniparental disomy 15 or an imprinting defect, and one AS patient (4.2%) showed an imprinting center deletion. Conclusions: MS-MLPA has clinical utility for the diagnosis of PWS/AS, and it is superior to MS-PCR in that it can identify the molecular mechanism underlying the disease.
Abstract
Background: Prader–Willi syndrome (PWS) and Angelman syndrome (AS) are genomic imprinting disorders that are mainly caused by a deletion on 15q11-q13, the uniparental disomy of chromosome 15, or an imprinting defect. We evaluated the utility of methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) as a diagnostic tool and for demonstrating the relationship between molecular mechanisms and clinical presentation. Methods: We performed MS-MLPA using DNA samples from 93 subjects (45 PWS, 24 AS, and 24 non-PWS/AS controls) who had previously undergone MS-PCR for the diagnosis of PWS/AS. We compared the results of both assays, and patients’ clinical phenotypes were reviewed retrospectively. Results: MS-MLPA showed a 100% concordance rate with MS-PCR. Among the 45 PWS patients, 26 (57.8%) had a deletion of 15q11-q13, and the others (42.2%) had uniparental disomy 15 or an imprinting defect. Among the 24 AS patients, 16 (66.7%) had a deletion of 15q11-q13, 7 AS patients (29.2%) had uniparental disomy 15 or an imprinting defect, and one AS patient (4.2%) showed an imprinting center deletion. Conclusions: MS-MLPA has clinical utility for the diagnosis of PWS/AS, and it is superior to MS-PCR in that it can identify the molecular mechanism underlying the disease.
참고문헌 (28)
- Õiglane-Shlik E, "Prevalence of Angelman syndrome and Prader–Willi syndrome in Estonian children : sister syndromes not equally represented", Am J Med Genet A, 140, pp.1936~1943 (2006)
- Botezatu A, "Comparative molecular approaches in Prader–Willi syndrome diagnosis", Gene, 575, pp.353~358 (2016)
- Ferreira IR, "A newborn screening pilot study using methylation-sensitive high resolution melting on dried blood spots to detect Prader–Willi and Angelman syndromes", Sci Rep, 10, pp.13026~ (2020)
- Ehrhart F, "Prader–Willi syndrome and Angelman syndrome : visualisation of the molecular pathways for two chromosomal disorders", World J Biol Psychiatry, 20, pp.670~682 (2019)
- Holm VA, "Prader–Willi syndrome : consensus diagnostic criteria", Pediatrics, 91, pp.398~402 (1993)
- Williams CA, "Angelman syndrome : consensus for diagnostic criteria", Am J Med Genet, 56, pp.237~238 (1995)
- Nicholls RD, "Imprinting in Prader–Willi and Angelman syndromes", Trends Genet, 14, pp.194~200 (1998)
- Butler MG, "Prader–Willi syndrome - clinical genetics, diagnosis and treatment approaches: an update", Curr Pediatr Rev, 15, pp.207~244 (2019)
- Buiting K, "Prader–Willi syndrome and Angelman syndrome", Am J Med Genet C Semin Med Genet, 154C, pp.365~376 (2010)
- Ramsden SC, "Practice guidelines for the molecular analysis of Prader–Willi and Angelman syndromes", BMC Med Genet, 11, pp.70~ (2010)
- Smith A, "The dilemma of diagnostic testing for Prader–Willi syndrome", Transl Pediatr, 6, pp.46~56 (2017)
- Nygren AO, "Methylation-specific MLPA(MS-MLPA) : simultaneous detection of CpG methylation and copy number changes of up to 40 sequences", Nucleic Acids Res, 33, pp.e128~ (2005)
- Kubota T, "Methylation-specific PCR simplifies imprinting analysis", Nat Genet, 16, pp.16~17 (1997)
- 신새암, "Routine Chromosomal Microarray Analysis is Necessary in Korean Patients With Unexplained Developmental Delay", Mental Retardation, Annals of Laboratory Medicine, pp.2015, 35(5)[DOI]
- 장우리, "Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay", Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea, 2019, pp.39(3), 299~310[DOI]
- Liu S, "Uniparental disomy of chromosome 15 in two cases by chromosome microarray : a lesson worth thinking", Cytogenet Genome Res, 152, pp.1~8 (2017)
- Kim HJ, "Genetic basis of Prader–Willi syndrome in Korea : less uniparental disomy than has been recognized?", Clin Genet, 66, pp.368~372 (2004)
- Butler MG, "Molecular genetic classification in Prader–Willi syndrome : a multisite cohort study", J Med Genet, 56, pp.149~153 (2019)
- Singh P, "Multicentre study of maternal and neonatal outcomes in individuals with Prader–Willi syndrome", J Med Genet, 55, pp.594~598 (2018)
- 김혜은, "Trends in Birth Weight and the Incidence of Low Birth Weight and Advanced Maternal Age in Korea between 1993 and 2016", Journal of Korean Medical Science, 34(4), pp.1~9 (2019), 대한의학회
- Butler MG, "Behavioral differences among subjects with Prader–Willi syndrome and type I or type II deletion and maternal disomy", Pediatrics, 113, pp.565~573 (2004)
- Kim SJ, "Unique and atypical deletions in Prader–Willi syndrome reveal distinct phenotypes", Eur J Hum Genet, 20, pp.283~290 (2012)
- Hassan M, "Prader–Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects", Eur J Med Genet, 59, pp.584~589 (2016)
- Kanber D, "A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader–Willi syndrome", Eur J Hum Genet, 17, pp.582~590 (2009)
- Hartin SN, "Three siblings with Prader–Willi syndrome caused by imprinting center microdeletions and review", Am J Med Genet A, 176, pp.886~895 (2018)
- Lu W, "Clinical and genetic features of Prader-Willi syndrome in China", Eur J Pediatr, 173, pp.81~86 (2014)
- Wang W, "Detection and discrimination between deletional and non-deletional Prader–Willi and Angelman syndromes by methylation-specific PCR and quantitative melting curve analysis", J Mol Diagn, 11, pp.446~449 (2009)
- Beygo J, "Update of the EMQN", ACGS best practice guidelines for molecular analysis of Prader–Willi and Angelman syndromes, 2019, pp.27, 1326~1340